Insulin actions and receptors were studied in capillary endothelial cells cultured from diabetic BB rats and their nondiabetic colony mates. The endothelial cells from diabetic rats of 2 mo duration had persistent biological and biochemical defects in culture. Compared with normal rats, endothelial cells from diabetic rats grew 44% more slowly. Binding studies of insulin and insulin-like growth factor I (IGF-I) showed that cells from diabetic rats had 50% decrease of insulin receptor binding (nondiabetic: 4.6 +/-0.7; diabetic: 2.6 +/-0.4% per milligram protein, P less than 0.01), which was caused by a 50% decrease in the number of binding sites per milligram protein, whereas IGF-I binding was not changed. Insulin stimulation of 2-deoxy-glucose uptake and alpha-aminoisobutyric acid uptake were also severely impaired with a 80-90% decrease in maximal stimulation, in parallel with a 62% decrease in insulin-stimulated autophosphorylation (P less than 0.05). 125I-insulin crosslinking revealed an 140-kD alpha subunit of the insulin receptor similar to that in cells from nondiabetic rats, although bands at greater than 200 kD were also detected. The molecular weight of the insulin receptor beta subunit (by SDS-PAGE) was smaller in cells from diabetic than from normal rats (88-90 vs. 95 kD). Neuraminadase treatment of the partially purified insulin receptors decreased the molecular weight of the insulin receptors from nondiabetic rats to a greater […] Abstract Insulin actions and receptors were studied in capillary endothelial cells cultured from diabetic BB rats and their nondiabetic colony mates. The endothelial cells from diabetic rats of 2 mo duration had persistent biological and biochemical defects in culture. Compared with normal rats, endothelial cells from diabetic rats grew 44% more slowly. Binding studies of insulin and insulin-like growth factor I (IGF-I) showed that cells from diabetic rats had 50% decrease of insulin receptor binding (nondiabetic: 4.6±0.7; diabetic: 2.6±0.4% per milligram protein, P < 0.01), which was caused by a 50% decrease in the number of binding sites per milligram protein, whereas IGF-I binding was not changed. Insulin stimulation of 2-deoxy-glucose uptake and a-aminoisobutyric acid uptake were also severely impaired with a 80-90% decrease in maximal stimulation, in parallel with a 62% decrease of insulin-stimulated autophosphorylation (P < 0.05). 125I-insulin cross-linking revealed an 140-kD a subunit of the insulin receptor similar to that in cells from nondiabetic rats, although bands at > 200 kD were also detected. The molecular weight of the insulin receptor,8 subunit (by SDS-PAGE) was smaller in cells from diabetic than from normal rats (88-90 vs. 95 kD). Neuraminadase treatment of the partially purified insulin receptors decreased the molecular weight of the insulin receptors from nondiabetic rats to a greater degree than its diabetic counterpart. In contrast, Northern blot analysis of insulin receptor mRNAs using human cDNA probes revealed two species of 9.4 and 7.2 kb with no difference in mRNA abundance between cells from diabetic and nondiabetic rats. We conclude that the exposure of capillary endothelial cells to a diabetic milieu in vivo can cause specific and persistent changes in the insulin receptor and insulin action.
Introduction
Microangiopathy is a major cause of morbidity in patients with diabetes mellitus. The pathogenesis of diabetic microangiopathy remains enigmatic, despite the acquisition of a great deal of knowledge concerning functional (1) (2) (3) , biochemical (4) , and morphological changes (5) in the vasculature of diabetic patients. These characteristic changes include increased regional vascular flow (1, 2) , increased microvascular permeability (3), capillary basement membrane thickening (4) , and the presence of microaneurysms and neovascularization (5) . It is likely that endothelial cells play an important role in the development of microangiopathy. Cellular abnormalities in growth have been reported previously in fibroblast and arterial smooth muscle cells cultured from diabetic animals and patients (6) (7) (8) , but specific biochemical abnormalities have not been identified in the vascular cells. Moreover, no study has characterized the abnormalities of capillary endothelial cells from diabetic human or animals. Abnormalities in insulin actions and receptor functions have recently been found in nonvascular tissues isolated from diabetic humans and animals (9) (10) (11) (12) . Because capillary endothelial cells have been shown previously to be insulin sensitive (13), abnormalities in these cells from diabetic animals may also occur. This study is a comparative analysis of capillary endothelial cells from diabetic and nondiabetic rats with respect to growth and insulin action, using BB and streptozotocin-induced diabetic rats. In the BB rat model of autoimmune insulin-dependent diabetes, -60% of the BB rats develop clinical ketosis prone diabetes at the age of 60-100 d (14) . A decrease in the retinal pericyte/endothelial cell ratio and thickening of capillary basement membrane similar to those reported in diabetic patients have been observed (15, 16) . In this work, we find a persistent biochemical abnormality in the insulin receptor and insulin action of cultured capillary endothelial cells from diabetic rats.
Methods
Materials. Tissue culture plasticware were obtained from Costar Corp. (Cambridge, MA). DME and Earle's media were from Irvine Scientific (Santa Ana, CA). Plasma-derived horse serum was from HyClone Laboratories (Logan, UT). Fibronectin and oligo (dT)-cellulose (type III) were purchased from Collaborative Research (Lexington, MA); collagenase was from Worthington Biochemicals (Freehold, NJ). '25I-A 14 Nondiabetic control rats. Five groups of nondiabetic rats (six rats per group) were used as controls. They were all derived from diabetic forebears. One group (six rats), through inbreeding, is composed of diabetic-prone BB rats that are now resistant to the disease. The other four groups (24 rats total) were diabetic-prone as the diabetic BB rats and were from the colony mates of the diabetic rats, except they had not developed diabetes at the time of killing. Because diabetic resistant groups and diabetic-prone groups behave the same with respect to insulin actions and receptor binding, they were considered together in this study. Cultures were prepared from these rats at the age of 130-150 d, comparable to the diabetic groups.
Streptozotocin-induced diabetic rats. Sprague-Dawley rats weighing 175-200 g were treated with 70 g/kg wt streptozotocin. All rats with glucose > 300 mg/dl were designated as diabetic and 50% of the diabetic rats survived for 8 wk without the use of insulin. Six rats with and without diabetes were maintained for 8 wk and then killed. The capillaries were isolated as described below.
Capillary endothelial cell cultures. Cells were prepared from epididymal fat pads of rats killed with an overdose of CO2 using a method similar to the one described for retinal endothelial cells ( 13). Briefly, the fat pads were dissected and minced into small pieces and incubated with 0.2% collagenase in a PBS. This mixture was homogenized and centrifuged with the supernatant discarded. The pellet was resuspended in Earle's medium and filtered through three nylon screens of decreasing mesh sizes of 210, 88, and 53 jim. Digested capillaries retained by the last nylon screen were collected by centrifugation and plated on fibronectin-coated tissue culture dishes in DMEM containing 100 mg/dl of glucose with 5% plasma-derived horse serum. The cells were then harvested by treatment with 0.05% trypsin with 0.2% EDTA and replanted in fibronectin-coated tissue culture dishes. The cell identity and the homogeneity of the culture were confirmed by phase-contrast microscopic morphology and the presence of Factor VIII antigen by immunofluorescence with specific antibodies (17) . No significant differences in growth or characteristics of insulin receptor were found between cells from the 5th to 30th passage, which were used in these studies. For cells used in testing the effect of elevated glucose level, endothelial cells were incubated in 400 mg/dl of D-glucose for 3-10 mo with the media changed every 2-3 d.
Growth parameters. Cell growth rates were measured by seeding the same number of trypsinized cells into 12-well (4.9 cm2) plates and cell counts were made 24 h later and every other day for the course of the experiment. Cells were counted in an electronic cell counter (Coulter Electronics, Hialeah, FL) after trypsin dissociation.
Binding studies. Binding of 1251-insulin to capillary endothelial cell monolayers of diabetic and non-diabetic BB rats was measured as described previously (18) . Briefly, confluent cell monolayers in 6-well plates were washed with Hepes buffer, pH 7.6, and then incubated for 4 h at 15°C, with 1 ml of Hepes buffer containing 0.5% BSA, 0.15 ng/ml of '25I-insulin (specific activity 350 ;tCi/;tmol) and various concentrations of unlabeled insulin. The specific binding of '25I-insulin was calculated by subtracting the amount of radioactivity bound in the presence of a high concentration of unlabeled porcine insulin (1.6 X 10-6 M) from the total radioactivity bound to cells. Protein content was determined in duplicate by method of Lowry et al. (19) . The same procedure was used to measure the binding of '251-IGF-I.
Determination of2-deoxy-D-glucose (2DG) uptake (20) . Cell monolayers were rinsed twice with PBS and incubated in DME with 0.5% BSA for 12 h and then incubated in glucose-free DME for 2 h at 370C in humidified 5% CO2, and 95% air. The cells were washed with PBS and then incubated with Krebs-Ringer phosphate-2.5% BSA with or without various concentrations of insulin for 30 min. ['4C]2DG (0.5 jiCi/well) was then added to the cells and incubated for 10 min. The radioactive medium was removed and cells washed with ice-cold PBS three times. The cells were solubilized with 1 ml 0.1% SDS and counted in liquid scintillation counter (1215 Rackbeta II; LKB Instruments, Gaithersburg, MD). The data were normalized to protein concentration.
Determination of a-amino isobutyric acid (AIB) uptake (21) . Cultured endothelial cells were rinsed with PBS and incubated in DME with 0.5% BSA at 370C for 12 h as previously described (21) . After washing and incubating for another 4 h in PBS with 0.5% BSA and 5 mM glucose in the presence or absence of various concentrations of insulin, [14C]AIB (0.5 jCi/well) was added to the mixture. After 1 h, the medium was quickly aspirated and the cells were washed three times with ice-cold PBS and solubilized with 0.1% SDS. The cell extract was counted in a scintillation counter.
[3H]Thymidine incorporation into DNA. Endothelial cells were grown to confluence at 370C in 12-well plates (4.9 cm2/well). The growth media was then replaced with DME containing 0.5% BSA for 24 h. The indicated hormones were added to each well and incubated for 18 h before pulsing with [3H]thymidine, 2 juCi/ml for 30 min at 370C. The cells were then solubilized in 0.1% SDS and precipitated with 10% cold TCA and counted in liquid scintillation fluid (22) .
Affinity labeling (23) . Binding was performed with '251-insulin (2.5 ng/ml, 350 ;tCi/mmol) at 1 5'C for 4 h in the presence and absence of unlabeled insulin as described previously using DSS. The cell lysates were boiled in Laemmli solution containing 0.1 M DTT and then analyzed in 0.1% SDS, 7.5% polyacrylamide gels using a discontinuous system with molecular weight standards of myosin, 200,000; (3-galactosidase, 116,250; phosphorylase B, 92,500; BSA 66,200; and ovalbumin, 45,000. The gels were stained with 0.25% Coomassie brilliant blue and autoradiographed with Kodak X-Omat film for 3 wk.
Insulin receptor phosphorylation. The insulin receptor autophosphorylation assay was performed using Triton X-100 to solubilize the cells, and purification of the receptor on a wheat-germ agglutinin (WGA) agarose column (24) . The partially purified receptor after normalization for insulin binding was incubated with different concentrations of insulin for 30 min at room temperature in the presence of 5 mM MnCI2. The phosphorylation reaction was initiated by adding 50 juM cold ATP and 100 jCi/tube 32P-ATP. After 8 min, the reaction was stopped by the addition of cold solution containing 50 mM NaF, 20 mM Na4P2O7, 5 mM EDTA, and 50 mM ATP and then immunoprecipitated with antireceptor antibody (serum B9 at 1:200). The immune complexes were precipitated with protein A (Calbiochem-Behring Corp., La Jolla, CA). After being washed three times, the pellets were solubilized and boiled in Laemmli buffer and submitted to SDS, 7.5% PAGE under reducing conditions (0.1 M DTT). The phosphorylated (3 subunit of the insulin receptor was identified by autoradiography and quantitated by scanning densitometry of the autoradiograms.
Neuraminidase treatment of insulin receptors was performed by incubating WGA-purified receptors with 2 U/ml neuraminidase at 37°C for 30 min in the presence of 0.1 mg/ml aprotinin. Autophosphorylation and identification of insulin receptor (3 subunits was then performed as described above.
Northern blot analysis of insulin receptor mRNA. Endothelial cell RNA was isolated by the method of Han et al. (25) and poly(A)+ RNA was selected by two passages over oligo(dT)-cellulose (26) . Poly(A)+ RNA was then separated on a 1% agarose-2.2 M formaldehyde gel and transferred to BioTrace RP Nylon paper with lOX SSC (I X SSC = 0.15 M NaCl/0.015 M Na citrate). Filters were baked at 80°C for 2 h, soaked at 65°C for I h in 0.1 X SSC/0.5% (wt/vol) SDS, and then prehybridized at 42°C for 16 h in a solution containing 50% formamide, 10% dextran sulfate, 0.45 M NaCI, 1% (wt/vol) SDS, 0.5% (wt/vol) nonfat dry milk, 0.5 mg/ml denatured salmon sperm DNA, 3 mM EDTA, 30 mM NaH2PO4 buffer, pH 7.4. Human insulin receptor cDNA fragments Eco RI 1,01 1 and 4,187 bp (27) were generously provided by Dr. Ora Rosen (Memorial-Sloan Kettering Cancer Center, New York, NY) and subcloned in SP 64 vectors. A 677-bp probe for the insulin receptor a subunit was generated by Xho I digestion of the 1,01 l-bp Eco RI fragment; a 1,599-bp probe for the 6 subunit was similarly produced by Pst I cleavage ofthe 4,187-bp Eco RI fragment. Probes were labeled with a-[32P]-dCTP to _1 X 109 dpm/ug using a random hexamer priming kit. Hybridization was for 16-20 h at 420C in prehybridization solution. Blots were washed successively in 2X SSC, 0.1% SDS, 0.5X SSC, 0.1% SDS and 0.1 X SSC, 0.5% SDS at room temperature followed by 0.1 X SSC, 0.5% SDS for 30 min at 50'C before autoradiography at -80'C.
Results
Growth parameters. The growth characteristics ofthe endothelial cells from the diabetic and nondiabetic rats were compared. For cells derived from nondiabetic BB rats, the average doubling time was 18±1.3 h and the cell density at confluency was (16.7±2.2) X 104 cells/cm2 (mean and SD of three independent cell isolates). In contrast, endothelial cells from the diabetic animals grew slower, with a doubling time of 32.3±4.7 h (P < 0.01) and had fewer cells at confluency (11.9±0.9) X 104 cells/cm2 (Table I) . A similar decrease in growth rate was observed in the cells harvested from streptozotocin-treated diabetic rats.
Biological effects ofinsulin. Because endothelial cells from the adipose tissue and other microvessels have been shown to be sensitive to insulin and IGF-I stimulation (13), the responsiveness of the endothelial cells from the diabetic and nondiabetic BB rats to insulin as measured by 2DG and AIB uptake was determined. Capillary endothelial cells from nondiabetic rats showed an increase of 2DG uptake when stimulated by insulin at 0.16 nM and reached the maximum of 180% ofbasal at 160 nM (Fig. 1) . Surprisingly, in cells from diabetic animals there was no stimulation of 2DG uptake by insulin at any concentration (Fig. 1) . Similarly, capillary endothelial cells from streptozotocin-treated rats did not respond significantly to insulin stimulation. Spermidine, which has been shown to increase glucose uptake into cells via a pathway that is probably distal to the insulin receptors had a similar stimulation of 2DG (50-70% maximum, n = 3) uptake in both diabetic and nondiabetic cells (data not shown).
In addition to glucose uptake, insulin's effect on amino acid uptake was measured using [14C]AIB with cells from nondiabetic rats, some stimulation ofuptake was observed with an insulin concentration of 0.16 nM and uptake reached its peak at 160 nM (Fig. 2 ), in parallel with 2DG uptake. By contrast, 2DG uptake was performed as described in Methods. Each point represents the mean and SE from three separate experiments using endothelial cells from three different groups of diabetic and nondiabetic BB rats. The difference in 2DG uptake between endothelial cells from diabetic and nondiabetic BB rats is significant at insulin concentrations of 1.6 X I0-' M with a P value < 0.01 as analyzed by the paired t test.
cells from the diabetic animals did not show any significant effect at any insulin concentration (Fig. 2) .
[3H] Thymidine incorporation into DNA. (Fig. 3) .
Insulin receptor. Because endothelial cells from diabetic rats of spontaneous origin (BB) and streptozotocin-induced rats were less responsive to insulin as compared with cells from nondiabetic animals, the insulin receptor on these cells was examined. '251I-insulin binding to cell surface receptors was decreased when the endothelial cells of diabetic rats were compared with those of nondiabetic rats. At tracer concentration, the endothelial cells from normal BB rats exhibited a 4.6±0.7% binding per milligram of cell protein, whereas endothelial cells cultured from diabetic rats bound only 2.6±0.4% per milligram protein, (P < 0.01) (Fig. 4) . In cells from Sprague-Dawley rats, the diabetic and nondiabetic rats had 1.9±0.6 and 3.4±0.4% per milligram protein, respectively. Scatchard analysis showed the change is due to receptor num- (Fig. 6 ). This band corresponds to the a subunit ofthe insulin receptor observed in other endothelial or nonendothelial tissues, although the apparent molecular weight of the receptor in endothelial cells is slightly higher than that in nonendothelial tissues. In addition, the major intense band or bands at > 200 kD were found that had been reported by us previously as cross-linked a subunit of the insulin receptor (30) . However, affinity labeling studies using divalent agents are not quantitative, because of uncertainty of the cross-linking efficiency in each experiment.
As a 50% decrease ofinsulin binding cannot account quantitatively for the severely impaired metabolic response to insulin in endothelial cells from diabetic BB rats, we further examined the kinase activity of the 1# subunit, which is believed to initiate some, if not all, ofthe biological actions of insulin (29) . The protein kinase activity of the subunit of the insulin receptor was examined using Triton X-100-solubilized and wheat-germ purified cell extract incubated with 732P-ATP and Mn2+ in the presence and absence of insulin. The receptors were then identified by immunoprecipitation with an antireceptor antibody (B9 serum), SDS-PAGE, and autoradiography. A band with a molecular mass of 95 kD that exhibited insulin-stimulated phosphorylation was observed in cells from nondiabetic animals (Fig. 7) . A variable band at 100 kD can also be observed and does not appear to be stimulated by insulin. In contrast, a smaller band at 88-90 kD was observed in endothelial cells from diabetic animals (Fig. 7) . Both bands are believed to be the subunit of the insulin receptor because they were stimulated by insulin and precipitated by anti-insulin receptor antibody. Quantitation ofautophosphorylation by densitometric scanning of these bands showed that in nondiabetic cells, insulin stimulated the phosphorylation of the receptor over a range of concentrations from 0. 16 to 160 nM, reaching a maximal on the average at eight times basal (Fig. 8 were not significant because of the large interexperimental variations found. Poly(A)+ RNA-from diabetic BB rat endothelial cells. Molecular weights were estimated using an RNA ladder with fragments of 9.5, 7.5, 4.4, and 2.4 kb (Bethesda Research Laboratories, Gaithersburg, MD).
are not significantly different, we evaluated the possibility that the carbohydrate side chain could be altered. Neuraminidase is an exoglycosidase that removes the terminal sialic acid residues from the carbohydrate moiety of glyco-proteins. When digested with neuraminidase, the : subunit of the insulin receptors from cells of nondiabetic rats had a decrease of molecular weight from 95 to 88 kD, whereas a much smaller change was observed for cells of diabetic rats, 90 to 88 kD (Fig. 10) .
Effect of hyperglycemia on insulin binding and receptor function. Because elevated glucose levels have been reported to alter the growth properties of endothelial cells (32), we examined the possibility that chronic hyperglycemia in vivo may be a causal factor for the alteration of the insulin receptor's binding and function. Capillary endothelial cells were exposed to 400 mg/dl of glucose for 3-10 mo and their insulin receptors were characterized by binding (Fig. 4) , phosphorylation, and function with respect to 2DG uptake. As shown in Fig. 4 and Table III, elevated glucose at this level did not alter the properties of insulin receptors. In addition, the growth of capillary endothelial cells exposed to glucose levels of 100 and 400 mg% did not differ, even after 10 mo of exposure.
Discussion
The pathogenesis of diabetic microangiopathy appears to be metabolic, because the severity of the retinopathy is associated with glycemic control ofdiabetic patients over a chronic duration (34) . Genetic susceptibility may still play a role, however (35) .
This study represents the first report on capillary endothelial cells from animals with diabetes. Cells from diabetic BB rats were found to have a slower growth rate than the nondiabetic controls, consistent with previous studies (6, 7, 36) reporting altered growth properties in fibroblasts cultured from diabetic patients, although contrasting findings have also been reported (37, 38) . Interestingly, smooth muscle cells cultured from diabetic BB rats have been shown to have a more rapid growth rate and greater density at confluence (8) . The reason for this discrepancy is unknown, although factors such as disease heterogeneity, duration, and difference in the types of cells used, could be responsible. The simultaneous findings of abnormalities in cellular growth and insulin actions could be coincidental. Alternatively, it is also possible that they are closely associated, since the absence of an insulin effect could be part of a general loss of nutrient uptake functions, such as glucose and amino acid transport, which are needed for cellular proliferation.
Surprisingly, the studies on the endothelial cells from diabetic BB rats cultured for up to 30 passages still manifested abnormalities in receptor sizes and function. The decrease in receptor binding is due to a decrease in total number ofsurface binding sites per milligram protein. Furthermore, the changes are not due to exposure to elevated glucose levels directly because chronic incubation of endothelial cells in high glucose medium did not reproduce this defect. It is possible that the decrease of insulin receptor could be due to 2 mo of insulin treatment before the diabetic rats were killed. However, this is unlikely since the decrease in binding remained in the capillary endothelial cells after long-term culturing. In addition, the cells from streptozotocin-induced diabetic rats also showed decrease in insulin-binding and action though insulin treatment was not used. The decrease in the receptor number is also reflected in insulin metabolic effects as measured by 2DG and AIB uptakes, estimating glucose and amino acid uptake, respectively. Endothelial cells from nondiabetic rats and bovine have been shown to be sensitive to insulin for metabolic effects, such as glucose transport, glucose incorporation into glycogen,-and amino acid transport (13, 40). In contrast, Corkey et al. (41) Insulin's effects on both glucose and amino acid uptake were severely impaired in endothelial cells from diabetic rats as compared with normal rats. Because spermidine's effect on inducing 2DG uptake is normal, the defect in the endothelial cells from diabetic rats is probably not due to alteration in the glucose transportation but located in or near the insulin receptors. However, the defects in insulin-stimulated metabolic effects cannot be accounted for by the decrease in insulin binding alone, since both the insulin sensitivity and responsiveness were impaired to a much greater degree than binding defects, suggesting the presence ofpostbinding defects (42) in endothelial cells from diabetic rats. This was further confirmed by the finding that the insulin-stimulated phosphorylation of the , subunit of insulin receptor, one of the earliest events that occurs upon binding of insulin (43) , was also decreased in endothelial cells from diabetic rats to a greater degree and comparable to the defect observed in insulin's effect. Since the defect in phosphorylation correlates in severity with the loss of metabolic effects of insulin, this postbinding defect could be responsible for the impairment of metabolic effects of insulin, although postreceptor defects were not excluded.
In contrast to the severe impairment of the metabolic actions of insulin (2DG and AIB uptake) found in diabetic cells, the growth promoting effects of insulin as measured by [3H]-thymidine incorporation was not different when cells from nondiabetic and diabetic rats were compared. This could be partly explained by the presence of unaltered IGF-I receptors on the endothelial cells, because the growth-promoting effects of insulin in endothelial cells may be mediated through the IGF-I receptor, which insulin can bind at with low affinity (13, [44] [45] [46] . The finding that IGF-I is apparently more potent than insulin supports this possibility. However, more studies are needed to confirm this speculation. Since in other capillary endothelial cells, insulin can be equally potent with IGF-I in its mediating growth effects (13). We are providing these data to show that not all the actions of insulin are affected in endothelial cells from diabetic rats.
The differences found between the cells from diabetic and nondiabetic rats may have occurred before the rats developed diabetes. Because the diabetic rats were derived from the same parents as the control rats and contained the same genetic material, this possibility is not likely, although not completely excluded. To answer this question, characterization of insulin action and its receptor in capillary endothelial cells from rats rendered diabetic with streptozotocin will be helpful and is currently in progress. An alternate explanation for these differences is that the culturing procedures may have resulted in the isolation ofa subpopulation ofinsulin resistant endothelial cells from diabetic rats. This possibility is minimized but not excluded by using cells from multiple preparations from a large number of rats, all of which showed similar findings in both early and late passages (5th to 30th). In addition, the cells from diabetic rats were cultured under the same conditions as the nondiabetic cells. We thus would conclude that the differences between the cells were present before the in vitro cultur- The alterations of insulin binding and action, and decreased tyrosine kinase activity were also found to be associated with a change in the /3 subunit electrophoretic mobility migration rate, suggesting changes in its structure. This association could be coincidental. However, it is also possible that the decrease in size of # subunit is responsible for the defects in insulin binding, action and phosphorylation. The difference in /3 subunit size is apparently not due to a major alteration in receptor gene expression, because the Northern analysis showed no obvious difference between capillary cells from diabetic and nondiabetic BB rats. However, this study does not rule out small changes in the RNA sequences that may not alter cDNA hybridization. Translational control and/or posttranslational modifications affecting both size and abundance of the receptor /3 subunit are more likely to account for the alterations observed in endothelial cells from the diabetic BB rats. Posttranslational changes could occur at the level of enzymatic glycosylation ofthe /3 subunit or other structural modifications of the peptide. The neuraminadase data further supports the likelihood of a posttranslational modifications in the glycosylation step. Further studies focused on peptide mapping and the carbohydrate moieties of the insulin receptor /3 subunit in capillary endothelial cells from diabetic animals and patients are in progress. The findings in the endothelial cells appear to be unusual among the various cells studied in the diabetic BB rats and other diabetic models. Previous studies by Okamoto et al. (47) did not reveal a molecular size change but did reveal tyrosine kinase activity changes. In addition, fibroblasts for the diabetic rats did not show any binding alterations. These findings would suggest that the changes in molecular size and actions of insulin receptors may be unique in the endothelial cells. Note that the insulin receptor in endothelial cells has the unusual property of processing insulin for the transcytosis pathway ( 18, 46, 48) . It thus would be tempting to suggest these two processes may be related.
The connection between this loss of insulin regulation in the capillary endothelial cells from diabetic rats to the development of diabetic microangiopathy will require further studies.
